Top science and technology news from Nebraska

Provided by AGP

Nebraska Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nebraska Tech Daily.

Press releases published on May 4, 2026

Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
AITX to Present at the LD Micro Invitational XVI
Mapi Pharma Explores U.S. Aseptic Manufacturing Facility to Support Growing Demand for Aseptic and Long-Acting Generic and innovative Injectables
Abeona Therapeutics® Announces Date of First Quarter Financial Results
Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress
Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6
Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

Share us

on your social networks:

Sign up for Nebraska Tech Daily.

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.